相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom et al.
GENE THERAPY (2021)
COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies
Shyam Rele
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa et al.
VACCINE (2021)
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O. Saunders et al.
NPJ VACCINES (2021)
The promise of mRNA vaccines: a biotech and industrial perspective
Nicholas A. C. Jackson et al.
NPJ VACCINES (2020)
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
Gregory D. Sempowski et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Markus Baiersdoerfer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
Robert D. Junkins et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
Norbert Pardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The quest for an antibody-based HIV vaccine
Barton F. Haynes et al.
IMMUNOLOGICAL REVIEWS (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies
Mattia Bonsignori et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS
Michael Beverly et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface
Melissa Samo et al.
VACCINE (2016)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
Barton F. Haynes et al.
NATURE BIOTECHNOLOGY (2012)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Industrialization of mAb production technology The bioprocessing industry at a crossroads
Brian Kelley
MABS (2009)
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques
S Capone et al.
JOURNAL OF VIROLOGY (2006)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
分享论文
